Adequate Duration of Antibiotic Treatment in Community-acquired Pneumonia With High Risk Class and Adequate Initial Clinical Response

NCT03609099 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

424

Enrollment

OTHER

Sponsor class

Conditions

Community-acquired Pneumonia

Interventions

DRUG: Moxifloxacin
DRUG: Placebo

Sponsor

David Garcia Cinca

Collaborators

[object Object]
[object Object]